Clinical Trial Update: MAINTAIN (Mucosal AblatIoN Therapy After INcretins) [NA]

View source ↗

Summary

The MAINTAIN trial evaluating mucosal ablation therapy after incretins for obesity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Dr. Christopher McGowan | Conditions: Obesity and Obesity-related Medical Conditions, Obesity and Overweight | NA | Status: RECRUITING